Federal Register #2026-19004

Notice of membership changes for Subcutaneous Drug Development & Delivery Consortium, Inc.

This notice from the Department of Justice, Antitrust Division, concerns the Subcutaneous Drug Development & Delivery Consortium, Inc. under the National Cooperative Research and Production Act. - Government Buyer: - Department of Justice, Antitrust Division - Consortium Membership Update: - Novo Nordisk (pharmaceutical OEM) has withdrawn from the consortium - No other changes to membership or planned activities - Membership remains open; future changes will be notified - Sector Focus: - Cooperative research and production in subcutaneous drug development and delivery - No procurement action: - No products, services, or contract awards are requested or announced - OEM Highlight: - Novo Nordisk is the only OEM mentioned - No product or service line items listed

Description

This notice pertains to the Subcutaneous Drug Development and Delivery Consortium, Inc., under the provisions of the National Cooperative Research and Production Act. It involves the Department of Justice, Antitrust Division. The notice discloses changes in membership of the consortium and extends provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Novo Nordisk has withdrawn as a party to this venture, but no other changes have been made in membership or planned activity. Membership remains open with intentions to file additional notifications of changes.

View original listing